Hims & Hers Selling GLP-1 Injection That’s Not FDA Approved, From Shady Supplier

Hims & Hers is selling a non-FDA approved GLP-1 weight loss drug through a loophole, bypassing the need for doctor consultations. The company's supplier, Belcher, has a history of fraud and bankruptcy. Patients have reported severe side effects from these knockoff drugs. Hims executives have sold shares worth millions since announcing the sale of these drugs. The company faces legal risks if the knockoffs are found unsafe or violate patents. Despite claims of compliance, concerns remain about patient safety and the legality of Hims' actions. The company's supplier, BPI Labs, has a shady history, including executives convicted of fraud. Hims' quick prescription process and lack of rigorous screening raise further red flags. Experts warn of potential legal and health risks associated with Hims' actions. The FDA has allowed compounded versions of GLP-1 drugs due to supply shortages, creating a chaotic market with counterfeit drugs. Insurance struggles and high costs have led some patients to opt for Hims' unapproved injections. Despite settlements and FDA approvals, questions persist about the safety and legitimacy of Hims' operations.